跳至主要内容
临床试验/NCT01153035
NCT01153035进行中(未招募)不适用

ABLATE Registry: Radiofrequency Ablation After Breast Lumpectomy (eRFA) Added To Extend Intraoperative Margins in the Treatment of Breast Cancer

University of Arkansas11 个研究点 分布在 1 个国家目标入组 104 人开始时间: 2010年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
104
试验地点
11
主要终点
Estimate the re-excision rate for close (<3mm) or positive margins

研究概览

简要总结

The purpose of this study will be to evaluate, in a multi-center setting, the ability of radiofrequency ablation (RFA) of breast cancer lumpectomy sites to extend the "final" negative margin and consequently decrease the rates of re-operation. During the initial breast conservation procedure (lumpectomy), immediately following routine surgical resection of the tumor, radiofrequency energy (RFA) is applied to the wall (bed) of the fresh lumpectomy cavity, thus extending tumor free margin radially beyond the volume of the resected specimen.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 100 Years(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Patient is a female, ≥ 50 years of age
  • •The tumor size is ≤ 3 cm (on pre-study radiologic OR clinical exam)
  • •The tumor is unicentric and unilateral
  • •The tumor is not involving the skin
  • •Pathology confirms ductal in situ (DCIS) OR infiltrating ductal carcinoma (IDC), grade I-III
  • •If tumor is IDC, pathology must be hormone receptor positive (ER+ and/or PR+)
  • •Patient signs current written informed consent and HIPAA forms

排除标准

  • •Patient is under 50 years of age
  • •Patient is male
  • •Tumor > 3 cm in diameter
  • •Bilateral malignancy
  • •Clinically positive lymph nodes
  • •Tumor involving the skin
  • •Pathology confirms invasive lobular carcinoma
  • •Breast implants
  • •Less than 2 years disease-free survival from previous breast cancer
  • •Neoadjuvant chemotherapy or chemotherapy for another breast cancer within two years

研究组 & 干预措施

Surgery followed by RFA

Other

干预措施: Radiofrequency Ablation (Device)

结局指标

主要结局

Estimate the re-excision rate for close (<3mm) or positive margins

时间窗: Post-surgery (defined as 2 weeks after surgery, to allow time for pathology to be completed)

How many patients must go back for re-excision of margins

Decrease local recurrence

时间窗: Monitor throughout 5 year follow-up

The patient will be followed closely from the time of surgery through a period of 5 years in order to assess the frequency of local recurrence, defined as a new diagnosis of cancer at or near the site of primary surgery. It is our thought that the addition of RFA to the standard surgical treatment will reduce the number of local recurrences.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (11)

Loading locations...

相似试验